JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:25 min • August 7th, 2025
Begin with a secured, anesthetized rat with implanted guide cannulas in the prefrontal cortex of its brain, a region associated with pain regulation.
Take a Hamilton syringe containing an analgesic or pain-relieving drug connected with an injector cannula via tubing.
Attach the injector cannula to the guide cannula and administer the drug intracranially over a predetermined period.
Administer a second analgesic drug intraperitoneally to study the synergistic effect of the two drugs.
Allow the animal to recover.
Place the freely moving animal on Hargreave’s apparatus.
Focus an infrared beam through the glass onto the rat’s paw.
As the rat withdraws its paw in response to thermal pain, the withdrawal latency time is recorded by the apparatus.
Analyze the data to evaluate the effect of intracranial injection and the co-administration of analgesic drugs on thermal pain perception.
To study the effect of intracranial injections on acute pain behavior in rats, one week after the surgery, place the rat onto the glass plate of a Hargreaves' apparatus and use the apparatus to focus an infrared beam through the glass plane under the planter area of one of the rat's feet.
To study the synergistic pharmacological effects between two different study drugs, use a piece of PE-50 tubing attached to a 10-microliter Hamilton syringe, equipped with a 33 gauge injector cannula that extends 1 millimeter beyond the implanted guides. Inject 0.5 microliters or less of the study drug into one intracranial cannula over a period of 100 seconds.
Keep the injector cannula in place for an additional 60 seconds after the injection to facilitate a slow diffusion of the solution. Then, intraperitoneally inject the second drug of interest. 20 to 30 minutes after the injection, perform the plantar reflex test five more times, as demonstrated.
This study investigates the effects of intracranial and intraperitoneal administration of analgesic drugs on thermal pain perception in rats. Using a Hargreaves' apparatus, the withdrawal latency in response to thermal stimuli is measured to assess pain behavior.
This protocol enables evaluation of synergistic analgesic effects through dual-route drug delivery, supporting target validation in CNS pain pathways. Quantitative thermal pain assessment provides mechanistic de-risking for analgesic combinations. The approach informs preclinical go/no-go decisions by clarifying pharmacological interactions before lead optimization.
This method integrates into the discovery continuum from target validation through lead identification to preclinical efficacy testing.
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Related Videos
0 Views
Last updated: 29 August 2026